SI-BONE announced the completion of a $33 million growth capital round of financing.
The funds will be used for the expansion of the U.S. sales organization as well as for the addition of resources in research and development, medical affairs, regulatory, compliance and reimbursement. The company also has plans to expand operations outside the U.S.
SI-BONE is a sacroiliac joint medical device company dedicated to the development of tools and products for diagnosing and treating patients with low back issues related to SI joint disorders, such as the iFuse Implant System.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws